3rd Quarter - Report

CGCN GROUP, LLC for EMERGENT BIOSOLUTIONS INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25 Naloxone access and awareness legislation State opioid response (SOR) Grant funding for FY25 Substance Abuse and Mental Health Block Grant (SABG) funding and FY25 NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone HANDS Act - H.R. 5506 SAVE Act of 2023 - H.R. 6161 Overdose Reversal Medication (ORM) Act - H.R. 6243 Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948 School Access to Naloxone Act of 2023 - H.R. 3065, S. 2946 Protecting Kids from Fentanyl Act of 2023 - H.R. 4582 Saving Lives in Schools Act of 2023 - H.R. 4240

LobbyistCovered position, as disclosed
JILL HAMAKER —
MARTHA BEATRICE MILLER —
SCOTT RIPLINGER —
JA'RON SMITH New —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 5420 (118th), H.R. 4582 (118th), H.R. 4240 (118th), S. 2948 (118th), H.R. 5506 (118th), H.R. 6161 (118th), H.R. 6243 (118th), S. 2946 (118th), H.R. 3065 (118th)

Disaster Planning/Emergencies DIS

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25 Naloxone access and awareness legislation State opioid response (SOR) Grant funding for FY25 Substance Abuse and Mental Health Block Grant (SABG) funding and FY25 NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone HANDS Act - H.R. 5506 SAVE Act of 2023 - H.R. 6161 Overdose Reversal Medication (ORM) Act - H.R. 6243 Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948 School Access to Naloxone Act of 2023 - H.R. 3065, S. 2946 Protecting Kids from Fentanyl Act of 2023 - H.R. 4582 Saving Lives in Schools Act of 2023 - H.R. 4240

LobbyistCovered position, as disclosed
JILL HAMAKER —
MARTHA BEATRICE MILLER —
SCOTT RIPLINGER —
JA'RON SMITH New —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 5506 (118th), H.R. 5420 (118th), H.R. 3065 (118th), H.R. 6161 (118th), H.R. 6243 (118th), S. 2948 (118th), H.R. 4240 (118th), S. 2946 (118th), H.R. 4582 (118th)

Health Issues HCR

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25 Naloxone access and awareness legislation State opioid response (SOR) Grant funding for FY25 Substance Abuse and Mental Health Block Grant (SABG) funding and FY25 NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone HANDS Act - H.R. 5506 SAVE Act of 2023 - H.R. 6161 Overdose Reversal Medication (ORM) Act - H.R. 6243 Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948 School Access to Naloxone Act of 2023 - H.R. 3065, S. 2946 Protecting Kids from Fentanyl Act of 2023 - H.R. 4582 Saving Lives in Schools Act of 2023 - H.R. 4240

LobbyistCovered position, as disclosed
JILL HAMAKER —
MARTHA BEATRICE MILLER —
SCOTT RIPLINGER —
JA'RON SMITH New —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 6243 (118th), H.R. 5506 (118th), H.R. 3065 (118th), H.R. 4582 (118th), S. 2948 (118th), H.R. 4240 (118th), H.R. 6161 (118th), H.R. 5420 (118th), S. 2946 (118th)

Homeland Security HOM

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25 Naloxone access and awareness legislation State opioid response (SOR) Grant funding for FY25 Substance Abuse and Mental Health Block Grant (SABG) funding and FY25 NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone HANDS Act - H.R. 5506 SAVE Act of 2023 - H.R. 6161 Overdose Reversal Medication (ORM) Act - H.R. 6243 Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948 School Access to Naloxone Act of 2023 - H.R. 3065, S. 2946 Protecting Kids from Fentanyl Act of 2023 - H.R. 4582 Saving Lives in Schools Act of 2023 - H.R. 4240

LobbyistCovered position, as disclosed
JILL HAMAKER —
MARTHA BEATRICE MILLER —
SCOTT RIPLINGER —
JA'RON SMITH New —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3065 (118th), H.R. 5506 (118th), S. 2948 (118th), H.R. 6161 (118th), S. 2946 (118th), H.R. 6243 (118th), H.R. 5420 (118th), H.R. 4240 (118th), H.R. 4582 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.